Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Valencia › NPI 1780668434
Hospital

Henry Mayo Newhall Memorial Hospital

Henry Mayo Newhall Memorial Hospital was paid $17.80M by Medicaid between Jan 2018 and Dec 2024, across 236 billing codes. Its largest line is 0450, Emergency room services — 20% of everything it billed.

33Billing provider infoHENRY MAYO NEWHALL MEMORIAL HOSPITAL
VALENCIA, CA 91355
33aNPI1780668434assigned 12/05/2005
28Total paid$17.80M
24GClaims830,985
24DCodes billed236
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#132 of 410
Median peer was paid$6.90M
This provider vs. median2.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018143,255$2.16M
2019121,446$3.21M
202086,935$1.73M
202199,797$2.03M
2022114,669$2.57M
2023141,244$3.26M
2024incomplete123,639$2.84M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 20% 88,862 80,146 $3.49M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.1% 3,805 3,386 $1.09M
74177 Computed tomography, abdomen and pelvis; with contrast material 5.6% 5,432 5,293 $1.00M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.1% 20,095 18,745 $904K
70450 Computed tomography, head or brain; without contrast material 4.8% 7,816 7,589 $862K
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.9% 6,107 5,035 $521K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.8% 24,387 21,007 $506K
80053 Comprehensive metabolic panel 2.7% 42,440 38,253 $488K
96375 Therapeutic injection; each additional sequential IV push 2.7% 17,683 15,593 $487K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.6% 4,761 4,656 $457K
99199 Unlisted special service, procedure or report 2.3% 9,186 8,225 $408K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.9% 43,690 39,199 $335K
224 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 5,701 $334K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.8% 3,984 $317K
72125 Computed tomography, cervical spine; without contrast material 1.7% 2,202 $304K
71045 Radiologic examination, chest; single view 1.7% 22,694 $304K
99284 Emergency room visit (serious) 1.7% 2,790 $300K
0121 1.7% 224 $296K
Z7502 1.4% 7,060 $255K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 1,152 $179K
84484 <1% 17,223 $170K
99283 Emergency room visit (moderate) <1% 2,427 $167K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 3,224 $159K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,895 $142K
J7030 Infusion, normal saline solution , 1000 cc <1% 22,881 $125K
85610 <1% 27,890 $120K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,172 $118K
83690 <1% 16,982 $108K
0270 <1% 19,630 $108K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13,757 $105K
0250 <1% 35,814 $101K
93971 <1% 1,129 $101K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 6,758 $101K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,866 $99K
J3490 Unclassified drugs <1% 24,014 $92K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,571 $91K
76830 Ultrasound, transvaginal <1% 1,529 $84K
83880 <1% 3,680 $83K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 3,280 $80K
83735 <1% 12,212 $79K
84703 <1% 12,978 $78K
84443 Thyroid stimulating hormone (TSH) <1% 5,341 $72K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 2,062 $68K
81001 <1% 13,617 $64K
87631 <1% 1,345 $63K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,666 $60K
76801 <1% 1,416 $59K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,361 $59K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 11,177 $58K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 586 $56K
81003 <1% 14,185 $55K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,232 $55K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,028 $54K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,789 $52K
0762 <1% 1,187 $51K
71046 Radiologic examination, chest; 2 views <1% 2,543 $50K
70486 <1% 401 $50K
80305 <1% 2,930 $50K
87040 <1% 4,460 $47K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 6,693 $47K
J2270 Injection, morphine sulfate, up to 10 mg <1% 7,679 $44K
72100 <1% 1,645 $44K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,674 $43K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,669 $43K
73562 <1% 2,219 $42K
73610 <1% 1,888 $42K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 188 $41K
96361 Intravenous infusion, hydration; each additional hour <1% 2,841 $41K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 6,883 $40K
87400 <1% 5,039 $37K
73630 <1% 2,000 $36K
96376 <1% 2,748 $36K
85379 <1% 3,532 $35K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,392 $34K
73030 <1% 1,641 $32K
80061 Lipid panel <1% 3,019 $32K
85730 <1% 6,158 $32K
80329 <1% 3,093 $32K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 749 $32K
83605 <1% 3,081 $28K
73130 <1% 1,409 $28K
80320 <1% 1,914 $27K
0160 <1% 671 $26K
87088 <1% 4,456 $26K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,186 $25K
73110 <1% 1,063 $22K
90715 <1% 786 $22K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,282 $21K
36415 Collection of venous blood by venipuncture <1% 26,080 $21K
84702 <1% 1,804 $20K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 674 $19K
80048 Basic metabolic panel (calcium, ionized) <1% 2,141 $18K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 674 $18K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,470 $17K
82947 <1% 6,101 $17K
87081 <1% 1,745 $17K
82150 <1% 3,066 $16K
87186 <1% 2,084 $15K
82077 <1% 1,036 $13K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 3,379 $13K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 2,863 $13K
72040 <1% 548 $13K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,259 $13K
80299 <1% 1,146 $13K
70496 <1% 57 $13K
76642 <1% 334 $13K
59025 Fetal non-stress test <1% 966 $12K
87807 <1% 1,001 $12K
70498 <1% 58 $12K
74018 <1% 619 $12K
0761 <1% 295 $11K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,331 $10K
86901 <1% 3,371 $10K
J2060 Injection, lorazepam, 2 mg <1% 2,305 $10K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 3,145 $9K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 858 $9K
S3620 Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) <1% 51 $9K
99213 Doctor's office visit, returning patient (routine) <1% 237 $9K
86900 <1% 3,353 $9K
83036 Hemoglobin; glycosylated (A1C) <1% 1,050 $8K
87077 <1% 1,317 $8K
73080 <1% 337 $8K
Z7610 <1% 641 $7K
85027 <1% 1,356 $7K
73590 <1% 322 $7K
J3475 Injection, magnesium sulfate, per 500 mg <1% 828 $7K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 52 $7K
99070 <1% 1,779 $7K
80143 <1% 551 $7K
29125 <1% 271 $7K
A4649 Surgical supply; miscellaneous <1% 911 $7K
93970 <1% 40 $6K
96367 <1% 215 $6K
73502 <1% 217 $5K
84145 <1% 158 $5K
J0780 Injection, prochlorperazine, up to 10 mg <1% 694 $5K
J1815 Injection, insulin, per 5 units <1% 337 $5K
84100 <1% 1,224 $5K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 15 $5K
76641 <1% 98 $4K
86850 <1% 898 $4K
80047 <1% 267 $4K
0710 <1% 907 $4K
J1650 Injection, enoxaparin sodium, 10 mg <1% 346 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 898 $4K
73090 <1% 156 $3K
90714 <1% 143 $3K
82550 <1% 564 $3K
S0164 Injection, pantoprazole sodium, 40 mg <1% 372 $3K
12001 <1% 38 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,064 $3K
81025 <1% 677 $3K
73140 <1% 210 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 549 $2K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 40 $2K
0301 <1% 454 $2K
84439 <1% 213 $2K
0324 <1% 350 $2K
84436 <1% 351 $2K
93017 <1% 30 $2K
0370 <1% 54 $2K
29515 <1% 47 $1K
86140 <1% 327 $1K
99000 <1% 363 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 72 $1K
J2704 Injection, propofol, 10 mg <1% 389 $1K
76870 <1% 27 $1K
87147 <1% 224 $1K
J0690 Injection, cefazolin sodium, 500 mg <1% 369 $1K
0637 <1% 667 $990.34
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 15 $958.61
J3360 Injection, diazepam, up to 5 mg <1% 102 $950.17
86308 <1% 62 $935.99
0403 <1% 60 $859.05
97161 <1% 40 $846.52
J3010 Injection, fentanyl citrate, 0.1 mg <1% 578 $834.77
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 2,588 $808.17
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 496 $799.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 16 $748.17
10060 <1% 59 $739.20
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,015 $729.82
12002 <1% 58 $686.02
82805 <1% 30 $676.94
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 29 $614.49
J2785 Injection, regadenoson, 0.1 mg <1% 13 $609.56
87070 <1% 90 $594.19
0420 <1% 75 $590.01
J7060 5% dextrose/water (500 ml = 1 unit) <1% 98 $553.13
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 503 $511.06
G0378 Hospital observation service, per hour <1% 17 $472.89
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 52 $468.26
J1953 Injection, levetiracetam, 10 mg <1% 32 $428.69
99232 Hospital visit by a doctor, follow-up day <1% 22 $415.04
0258 <1% 407 $408.04
0360 <1% 74 $394.24
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 660 $350.78
J1630 Injection, haloperidol, up to 5 mg <1% 84 $326.11
J2550 Injection, promethazine hcl, up to 50 mg <1% 68 $296.10
12011 <1% 12 $288.81
J7510 Prednisolone oral, per 5 mg <1% 154 $246.78
94644 <1% 14 $217.66
85652 <1% 126 $201.62
80076 <1% 47 $187.59
73060 <1% 14 $184.62
82010 <1% 30 $166.98
73552 <1% 14 $155.32
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 81 $139.73
87210 <1% 54 $138.42
87205 <1% 26 $78.16
J7612 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg <1% 46 $76.46
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 33 $71.41
0636 <1% 320 $62.56
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 12 $62.26
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 119 $62.06
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 12 $61.84
97016 <1% 53 $55.16
0260 <1% 18 $49.60
99072 <1% 27 $39.54
29130 <1% 12 $36.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 16 $24.68
J8597 Antiemetic drug, oral, not otherwise specified <1% 73 $18.40
C9113 Injection, pantoprazole sodium, per vial <1% 14 $10.08
0305 <1% 381 $4.97
0302 <1% 57 $4.09
0307 0% 129 $0.00
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session 0% 1,469 $0.00
Q4051 Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) 0% 42 $0.00
0352 0% 13 $0.00
0306 0% 62 $0.00
93042 0% 33 $0.00
0300 0% 489 $0.00
0730 0% 105 $0.00
0940 0% 55 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 13 $0.00
99499 0% 18 $0.00
0760 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSEAVER, ROGER (PRESIDENT AND C.E.O.)